Consensus Statement on Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring

DOI Web Site
  • Kobayashi Tetsuro
    Third Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi
  • Namba Mitsuyoshi
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine Diabetes Therapeutics and Research Center
  • Kuroda Akio
    Diabetes Therapeutic and Research Center, The University of Tokushima
  • Matsuhisa Munehide
    Diabetes Therapeutic and Research Center, The University of Tokushima
  • Yamada Kentarou
    Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine
  • Imamura Youichi
    AOZORA CLINIC
  • Kaneshige Masahiro
    Third Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi
  • Hamaguchi Tomoya
    Division of Innovative Diabetes Treatment, Department of Internal Medicine, Hyogo College of Medicine
  • Kawamura Tomoyuki
    Department of Pediatrics Osaka City University Graduate School of Medicine
  • Satoh Jo
    NTT-EAST Tohoku Hospital
  • Takahashi Kazuma
    Department of Internal Medicine, Iwate University
  • Maruyama Tarou
    Department of Internal Medicine, Saitama Social Insurance Hospital
  • Nishimura Rimei
    Division of Diabetes,, Metabolism and Endocrinology Department of Internal Medicine Jikei University School of Medicine
  • Katsuno Tomoyuki
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine Diabetes Therapeutics and Research Center
  • Kusunoki Yoshiki
    Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine Diabetes Therapeutics and Research Center
  • Shimizu Ikki
    Department of Diabetes, The Sakakibara Heart Institute of Okayama
  • Yanagisawa Katsuyuki
    Department of Diabetes and Endocrinology, Sapporo City General Hospital
  • Awata Takuya
    Division of Endocrinology and Diabetes, Faculty of Medicine, Saitama Medical University
  • Amemiya Shin
    Department of Pediatrics, Faculty of Medicine, Saitama Medical University
  • Association for the Study of Innovative Diabetes Treatment in Japan

Bibliographic Information

Other Title
  • 日本先進糖尿病治療研究会によるCSIIおよびCGMに関するステートメント
  • ニホン センシン トウニョウビョウ チリョウ ケンキュウカイ ニ ヨル CS Ⅱ オヨビ CGM ニ カンスル ステートメント

Search this article

Abstract

The use of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) in clinical practice is increasing in Japan. Against this background, the Association for the Study of Innovative Diabetes Treatment in Japan (ASINDTJ) arranged a Consensus Statement of opinions for the optimal and safe routine use of CSII and CGM. The Consensus Statement on the routine use of CSII and CGM includes patient selection and indications for clinical outcomes as well as risk management for routine use. The development of patient educational programs conducted by diabetologists in association with certified diabetes educators (CDEs) regarding the use of pumps and/or CGM is a prerequisite for clinical use. In addition, items associated with CSII and CGM, such as insulin dose adjustment, application methods for use in daily life, diet and exercise, risk management of pump difficulties, " sick day" occasions and skin problems, are included in the Consensus Statement. Our consensus opinion and suggestions also emphasize the usefulness of CSII and CGM in adult diabetic patients as well as children with type 1 and type 2 diabetes and pregnant diabetic patients. According to the Consensus Statement, the development of detailed educational guidelines for the use of CSII and CGM is needed.

Journal

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top